Handelsbanken Fonder AB boosted its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 58.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 77,706 shares of the real estate investment trust's stock after purchasing an additional 28,700 shares during the period. Handelsbanken Fonder AB's holdings in Sabra Health Care REIT were worth $1,446,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of SBRA. Family Firm Inc. purchased a new stake in shares of Sabra Health Care REIT during the second quarter valued at $26,000. Neo Ivy Capital Management acquired a new position in shares of Sabra Health Care REIT in the fourth quarter valued at about $41,000. GAMMA Investing LLC raised its stake in shares of Sabra Health Care REIT by 40.0% in the second quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust's stock worth $57,000 after purchasing an additional 1,052 shares during the last quarter. Newbridge Financial Services Group Inc. acquired a new stake in shares of Sabra Health Care REIT during the fourth quarter worth about $56,000. Finally, Future Financial Wealth Managment LLC purchased a new stake in Sabra Health Care REIT in the first quarter valued at approximately $89,000. Institutional investors and hedge funds own 99.40% of the company's stock.
Sabra Health Care REIT Price Performance
NASDAQ SBRA traded up $0.28 during trading hours on Friday, reaching $18.02. The company's stock had a trading volume of 942,567 shares, compared to its average volume of 2,043,442. The company has a debt-to-equity ratio of 0.89, a current ratio of 4.27 and a quick ratio of 4.27. Sabra Health Care REIT, Inc. has a 1-year low of $12.83 and a 1-year high of $19.32. The company's 50-day moving average is $17.48 and its two-hundred day moving average is $15.71. The firm has a market capitalization of $4.22 billion, a price-to-earnings ratio of 85.81, a P/E/G ratio of 2.59 and a beta of 1.26.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by ($0.24). Sabra Health Care REIT had a net margin of 7.83% and a return on equity of 1.87%. The company had revenue of $176.14 million during the quarter, compared to analyst estimates of $166.54 million. During the same period in the prior year, the business posted $0.34 EPS. Sabra Health Care REIT's revenue was up 9.3% compared to the same quarter last year. On average, equities analysts predict that Sabra Health Care REIT, Inc. will post 1.38 EPS for the current year.
Sabra Health Care REIT Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 19th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.66%. The ex-dividend date of this dividend was Monday, August 19th. Sabra Health Care REIT's payout ratio is 571.43%.
Analysts Set New Price Targets
SBRA has been the subject of a number of recent research reports. Scotiabank raised their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a research report on Friday. Citigroup upgraded shares of Sabra Health Care REIT from a "neutral" rating to a "buy" rating and boosted their target price for the company from $17.00 to $20.00 in a research report on Friday, September 13th. Wells Fargo & Company raised shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and upped their price target for the company from $16.00 to $20.00 in a report on Tuesday, October 1st. Finally, Truist Financial lifted their price objective on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a research note on Wednesday, September 4th. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, Sabra Health Care REIT presently has an average rating of "Moderate Buy" and an average target price of $18.11.
Check Out Our Latest Analysis on Sabra Health Care REIT
About Sabra Health Care REIT
(
Free Report)
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
See Also
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
